Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Kidney Int. 2014 Jun 11;86(6):1150–1160. doi: 10.1038/ki.2014.196

Figure 6.

Figure 6

Glucocorticoids and thiazolidinediones inhibit SA-induced COX-2. Serum–starved podocytes were treated with 20 mg/ml BSA for 4 h following pre-treatment with 1 μM dexamethasone (Dex), 10 μM rosiglitazone (Rosi) and 0.1 μM pioglitazone (Pio) for 24 h. A) COX-2 and GAPDH protein were visualized by immuno-blot analysis, and B) COX-2 mRNA levels were quantified by qRT-PCR and normalized to β-actin (***P<0.001 versus control; ***P<0.001 versus BSA, determined by one way ANOVA).